Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.66 |
| ▸ | TSHR | P16473 | 2/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | CES1 | P23141 | 2/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL54880 | 0.95 | ALDH1A1 (0.66) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL7596117 | 0.92 | ALDH1A1 (0.58) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL12501661 | 0.92 | ALDH1A1 (0.58) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL30917331 | 0.92 | ALDH1A1 (0.58) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL9798039 | 0.90 | CYP3A4 (0.75) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL13307462 | 0.90 | ALDH1A1 (0.56) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL28815673 | 0.88 | ALDH1A1 (0.58) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL11689544 | 0.88 | ALDH1A1 (0.58) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL1363427 | 0.86 | ALDH1A1 (0.56) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL1928079 | 0.86 | ALDH1A1 (0.56) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118685993-B | Antibacterial breathable fabric and preparation process thereof | 广东健业纺织集团有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-118772601-A | Preparation method of nano silicon dioxide composite material | 中科国京(合肥)控股有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-118685993-A | Antibacterial breathable fabric and preparation process thereof | 广东健业纺织集团有限公司 | 2024-09-24 | — | — | CN | claimed |
| CN-112713361-A | Composite lithium-sulfur battery diaphragm and preparation method and application thereof | 中国石油化工股份有限公司 | 2021-04-27 | — | — | CN | claimed |
| EP-4745634-A1 | COMPOSITION, OPTICALLY ANISOTROPIC FILM, AND COMPOUND | FUJIFILM Corporation (JP) | 2026-05-20 | — | — | EP | disclosed |
| EP-3985001-B1 | PHARMACEUTICAL COMPOSITION FOR USE IN TREATING A CANCER | SERVIER LAB (FR) | 2026-04-29 | — | — | EP | disclosed |
| US-20260092215-A1 | COMPOSITION, OPTICALLY ANISOTROPIC FILM, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2026-04-02 | — | — | US | disclosed |
| WO-2025045826-A1 | COMPOUNDS FOR ACTIVATION OF FGFR1 SIGNALING | THE CULTIVATED B. GMBH (DE) | 2025-03-06 | — | — | WO | disclosed |
| CN-118685993-B | Antibacterial breathable fabric and preparation process thereof | 广东健业纺织集团有限公司 | 2025-02-18 | — | — | CN | disclosed |
| WO-2025013902-A1 | COMPOSITION, OPTICALLY ANISOTROPIC FILM, AND COMPOUND | 富士フイルム株式会社 | 2025-01-16 | — | — | WO | disclosed |
| US-20240425445-A1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | MILLIKEN & CO (US) | 2024-12-26 | — | — | US | disclosed |
| CN-221965301-U | Device and system for continuously producing 5-nitro dimethyl isophthalic acid by micro-channel | 成都艾必克医药科技有限公司 | 2024-11-08 | — | — | CN | disclosed |
| US-4108890-A | Nitro or amino phenylenebis(carbonylimino)dinaphthalenetrisulfonic compounds as complement inhibitors | AMERICAN CYANAMID COMPANY (US) | 1978-08-22 | — | — | US | disclosed |
| US-4102917-A | COMPLEMENT INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1978-07-25 | — | — | US | disclosed |
| US-4102918-A | Anionic phenylcarboxamide complement inhibitors | AMERICAN CYANAMID COMPANY (US) | 1978-07-25 | — | — | US | disclosed |
| US-4087613-A | 1,3,5- Or 1,3,6-naphthalenetriyltris(sulfonylimino)aryl acids and salts | AMERICAN CYANAMID COMPANY (US) | 1978-05-02 | — | — | US | disclosed |
| US-4051176-A | COMPLEMENT INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1977-09-27 | — | — | US | disclosed |
| US-4051123-A | Sulfonic-acid-group containing disazo dyestuffs | CIBA-GEIGY AG (CH) | 1977-09-27 | — | — | US | disclosed |
| US-3945989-A | Fluoro triazine containing water insoluble azo dyestuff | CIBA-GEIGY AG (CH) | 1976-03-23 | — | — | US | disclosed |
| US-3931142-A | Heterocyclic containing disazo compounds | CIBA-GEIGY AG (CH) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240425445-A1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | PTAR1, TIPRL, TCOF1 | ALDH1A1 4713/4885TSHR 2279/4885CYP3A4 2357/4885 |
| US-20260092215-A1 | COMPOSITION, OPTICALLY ANISOTROPIC FILM, AND COMPOUND | SMC1A, SMC2, SMC3 | ALDH1A1 3561/4885TSHR 3451/4885CYP3A4 4330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.